We are excited to invite you to the upcoming EFCCA Conference "What do IBD patients find important in their treatment? - Results from a global Patient
Preference survey” that will take place on...
Registrations are open! This non-invasive technique is emerging as a valuable tool for diagnosis, treatment, and disease monitoring in IBD patients. Don’t miss this opportunity to learn and share your views!
Aiming to revolutionise personalised prevention and early treatment in chronic inflammatory diseases (CIDs), the PerPrev-CID project focuses on advancing risk prediction, early detection of disease progression, and innovative preventive approaches in...
Registrations are open for the 1st GlycanTrigger Patients Symposium, an important event we are co-organising together with the Portuguese Society for Innovation (SPI), focused on collaborative discussions around strategies for predicting and...
On 12 October 2024, EFCCA organised a conference during UEG Week (Vienna) titled: "How can patients play a crucial role in medicines-related decision-making? An open dialogue with stakeholders and the presentation of the EFCCA...
We’re excited to present the latest issue of the EFCCA Magazine, now with a refreshed design! Inside, you’ll find an exclusive interview with Professor James Lee, who shares insights on his groundbreaking research into the causes...
EFCCA is excited to introduce a series of webinars, workshops and initiatives to be launched after the summer break.
Read the exclusive interview with Dr. James Lee, whose revolutionary research into a major cause of Inflammatory Bowel Disease (IBD) has been published in the Nature journal. ...
We are pleased to announce the release of two significant reports that highlight our continuous efforts and achievements in advocating for improved IBD care and quality of life worldwide.
This year the central theme for World IBD Day is "IBD Has No Borders", emphasising the global nature of IBD and the need for collective action. ...